Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis Clinical research trials and Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis. Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis clinical trial. Human subjects often get the best healthcare possible for their Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.

Home > "P" Clinical Trials Conditions > Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis

Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis



Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis

For Condition: Osteoporosis
Status: Not yet recruiting
Sponsor(s): FDA Office of Orphan Products Development , Medical University of South Carolina
Synopsis: OBJECTIVES: I. Determine the effects of alendronate sodium on skeletal remodeling and bone mineral density of the hip and spine in children with high-turnover idiopathic juvenile osteoporosis.
Details: PROTOCOL OUTLINE: Patients receive oral alendronate sodium daily for 1 year. Treatment continues in the absence of disease progression or unacceptable toxicity.
Eligibility:
Study Type:  Interventional, Treatment
Minimum Age/Maximum Age: 5 Years/14 Years
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Diagnosis of high-turnover osteoporosis with no underlying cause (e.g., malignancy, hyperthyroidism, hyperparathyroidism, or vitamin D intoxication) Bone mineral density by DEXA at 2 standard deviations (SD) below normal mean for age (Z-score at least 2 SD below normal mean at the lumbar spine or hip) History of at least 1 atraumatic fracture, or evidence of at least 1 compression fracture on radiograph of the spine (reduction of at least 20%) No marked kyphoscoliosis or inability to sit or stand for at least 30 minutes No active rickets, osteomalacia, or bone alkaline phosphatase more than 2 times normal for age No osteogenesis imperfecta (including family history) or blue sclerae --Prior/Concurrent Therapy-- Prior course of prednisone allowed No concurrent prednisone except inhaled steroids No concurrent high-dose glucocorticoids No concurrent salmon calcitonin No other concurrent bisphosphonates No concurrent long-term anti-seizure medication --Patient Characteristics-- Hepatic: - SGPT no greater than 2 times upper limit of normal for age - Bilirubin no greater than 2.0 mg/dL Renal: - Creatinine no greater than 1.5 mg/dL - No uncorrected hypocalcemia Other: - No deafness - Weight more than 30 kg - Sexual development no greater than Tanner II - No severe gastritis or reflux - No gastric or duodenal ulcers - No abnormalities of the esophagus that delay emptying (e.g., strictures or achalasia) - No hypersensitivity to bisphosphonates
Total Enrollment: 12

Location and Contact Information:

Overall Study Official:
L.Key,  Study Chair,  Medical University of South Carolina


Additional Information:
Study ID Numbers:  199/15705;  MUSC-FDR001847
Study Start Date: 
Record last reviewed: February 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00010439

Other Osteoporosis Studies:
1. The relationship between Vitamin D, fingernail thickness and bone density

2. Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss

3. Zometa - Femara Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women with Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

4. PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis

5. Women's Health Initiative (WHI)

Related Studies:

Other Osteoporosis Clinical Trials
Other Clinical Trials
Other Clinical Trials

Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
Modify your Search

  Other Osteoporosis Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103